Johnson & Johnson (JNJ) Cost of Revenue (2009 - 2026)

Johnson & Johnson has disclosed Cost of Revenue across 18 years of filings, most recently posting $8.1 billion for Q1 2026.

• Cost of Revenue for Q1 2026 came in at $8.1 billion, up 10.18% year-over-year; the trailing twelve-month figure through Mar 2026 was $31.0 billion (up 9.49% YoY), and the FY2025 annual result was $30.3 billion, up 10.14% from the prior year.
• Cost of Revenue came in at $8.1 billion for Q1 2026 at Johnson & Johnson, up from $8.0 billion in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $8.1 billion in Q1 2026 to a low of $2.7 billion in Q1 2023.
• The 5-year median for Cost of Revenue is $7.0 billion (2024), against an average of $6.9 billion.
• Peak annual rise in Cost of Revenue reached 152.15% in 2023, while the deepest fall reached 18.4% in 2023.
• Johnson & Johnson's Cost of Revenue stood at $6.2 billion in 2022, then increased by 10.14% to $6.8 billion in 2023, then grew by 4.85% to $7.1 billion in 2024, then increased by 11.78% to $8.0 billion in 2025, then gained by 1.73% to $8.1 billion in 2026.
• The last three Cost of Revenue figures came in at $8.1 billion (Q1 2026), $8.0 billion (Q4 2025), and $7.3 billion (Q3 2025), per Business Quant data.